Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Elan Corporation, plc (ELN) -- Ignore unavailable to you. Want to Upgrade?

To: Qualified Opinion who wrote (3387)	10/9/2002 7:19:42 PM
From: Icebrg	Read Replies (1) \| Respond to of 10345

Rob, The focus of the article was not Elan and Elan's current problems. It was the impact Elan's problems has had and will have on local companies involved in joint-ventures with Elan. There really was no reason for the journalist to argue for or against Elan's survival. I think the article indirectly was interesting from an Elan-point-of-view as it shows: - that Elan is serious about shutting down unwanted j/vs as fast as possible, - that it should not be taken as granted that all j/vs will be discontinued. Those which fit well enough into the new Elan structure will continue to be supported. Like for example the work done at Curis. Ice